Life Science Instrumentation - Global Strategic Business Report 2026-2032 Featuring ACHB Enterprise, Agilent Technologies, BD, Bio-Rad Labs, Bruker Corp., ChromaCode, Danaher Corp., Emerson Electric Co., Eppendorf, GE Healthcare, Hitachi High-Tech Corp.
Dublin, Nov. 04, 2026 (GLOBE NEWSWIRE) -- "Life Science Instrumentation - Global Strategic Business Report 2026" has been added to ResearchAndMarkets.com's offering.
The global life science instrumentation market, valued at US$57.8 billion in 2025, is projected to reach US$90.2 billion by 2032, expanding at a compound annual growth rate (CAGR) of 6.6%. Market growth is supported by rising investment in biomedical research, technological innovation, personalized medicine, high-throughput analysis and expanding research activity across genomics, proteomics, metabolomics and cell biology.
Key Life Science Instrumentation Market Trends and Growth Drivers
Life science instrumentation is central to research, clinical diagnostics, drug discovery and biopharmaceutical development. Mass spectrometers, chromatography systems, microscopes, sequencing platforms, flow cytometers and related technologies enable molecular and cellular analysis with increasing precision, resolution and reproducibility. Growing research complexity and expanding data requirements are accelerating demand for advanced laboratory instruments across pharmaceutical companies, biotechnology organizations, hospitals, diagnostic laboratories and academic institutions.
Automation and robotics are transforming laboratory workflows by increasing throughput, reducing manual intervention and supporting consistent results. High-throughput screening is becoming increasingly important in drug discovery and clinical research, encouraging investment in integrated systems capable of rapidly processing large sample volumes. Artificial intelligence-enabled analysis, digital laboratory platforms and connected instruments are also supporting more efficient data interpretation and workflow management.
Imaging advances, including super-resolution microscopy and cryo-electron microscopy, are enabling increasingly detailed analysis of biological structures. Portable and miniaturized instruments are extending testing and research capabilities beyond conventional laboratory environments. These developments are broadening access to analytical technologies while creating new opportunities for instrument manufacturers and laboratory solution providers.
Personalized medicine remains a major source of market demand because genetic and molecular profiling requires highly accurate analytical platforms. Research involving synthetic biology, next-generation sequencing and CRISPR gene editing is also increasing demand for specialized instrumentation. At the same time, the growing prevalence of chronic diseases is supporting investment in biomedical research, diagnostics and therapeutic development.
Market Segment and Regional Highlights
Report Scope
The report analyzes the global life science instrumentation market by value in US dollars and provides annual sales estimates and forecasts from 2025 through 2032.
Strategic Value of the Report
Key Questions Addressed
Featured Companies
The report includes company profiles and competitive insights for organizations participating in the global life science instrumentation market, including:
Domain Expert Insights and Market Intelligence
The global life science instrumentation market is positioned for sustained expansion as research organizations, healthcare providers and commercial laboratories invest in more accurate, automated and scalable analytical technologies. Continued progress in precision medicine, molecular diagnostics, advanced imaging, sequencing and laboratory automation is expected to support demand through 2032.
Key Attributes
For more information about this report visit https://www.researchandmarkets.com/r/izmpj6
About ResearchAndMarkets.com
ResearchAndMarkets.com is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.